Trial intelligence / Profile preview

Intravenous magnesium sulfate vs placebo for postoperative pain and catheter discomfort after transurethral ureterolithotripsy

IRCT201410229014N45Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Jun 1992
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in nephrolithiasis comparing Magnesium sulfate with Placebo (2 arms). Primary endpoints: Postoperative pain intensity and Urethral catheter-related discomfort. Started Jun 1992; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on IRCT201410229014N45.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201410229014N45.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call